Our evaluation and opinions of the EPI-321 clinical trial design and potential based on the pre-clinical data
Update: 2025-09-06
Description
"But did you bleed him? - Aesculapius says that bleeding is not a cure. It is only a way of proving that you are a physician at the expense of your patient." Finally, we discuss the EPI-321 epigenetic editing phase I/II clinical trial design and its potential for answering key questions necessary for going to phase III and for providing benefit to participants and patients.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
